▁Introduction 10.375
: 6.5078125
<0x0A> 4.01953125
Ind 6.484375
ian 2.111328125
apolis 4.28125
- 4.02734375
based 0.4130859375
▁ph 7.484375
arma 0.22900390625
ce 0.10009765625
ut 0.00013327598571777344
ical 0.0004105567932128906
▁giant 2.646484375
, 4.19140625
▁Eli 0.18359375
▁L 0.024017333984375
illy 0.01165771484375
▁& 2.359375
▁Co 0.50634765625
, 2.208984375
▁is 1.724609375
▁set 3.775390625
▁to 0.0232696533203125
▁announ 3.255859375
ce 0.0007543563842773438
▁its 2.00390625
▁third 3.49609375
- 0.732421875
qu 0.00439453125
arter 0.0001277923583984375
▁ear 0.7783203125
nings 0.0244293212890625
, 3.64453125
▁and 2.81640625
▁industry 6.67578125
▁exper 1.68359375
ts 0.00020396709442138672
▁anticip 4.5546875
ate 0.01311492919921875
▁a 1.4599609375
▁positive 3.935546875
▁traject 7.1484375
ory 0.0009784698486328125
▁for 0.947265625
▁the 0.294921875
▁company 0.58349609375
. 0.72900390625
▁Ex 6.609375
pect 0.5537109375
ations 0.3408203125
▁are 0.72607421875
▁high 1.0419921875
▁for 1.0537109375
▁increased 6.26953125
▁prof 2.6328125
its 0.0018253326416015625
, 1.462890625
▁driven 3.263671875
▁by 0.225341796875
▁robust 4.5859375
▁sales 1.037109375
▁of 0.32861328125
▁key 4.61328125
▁dru 1.107421875
gs 4.5418739318847656e-05
▁amid 6.93359375
▁the 1.5126953125
▁on 2.466796875
going 0.0401611328125
▁COVID 1.1806640625
- 0.01861572265625
1 0.0020809173583984375
9 3.2901763916015625e-05
▁pan 0.0869140625
demic 0.00017750263214111328
. 0.25146484375
▁However 2.8515625
, 0.002422332763671875
▁anal 2.892578125
yst 0.001010894775390625
s 0.02392578125
▁are 1.119140625
▁vo 7.3359375
icing 0.004009246826171875
▁concerns 0.9091796875
▁over 1.0048828125
▁potential 3.8046875
▁profit 4.265625
▁margin 4.3125
▁challeng 5.06640625
es 9.429454803466797e-05
▁faced 5.12890625
▁by 0.09375
▁the 0.5185546875
▁company 0.3916015625
. 1.5107421875
▁This 4.453125
▁article 2.42578125
▁del 4.66796875
ves 0.06329345703125
▁into 0.41015625
▁the 0.7275390625
▁factors 2.373046875
▁contrib 3.517578125
uting 0.00015938282012939453
▁to 0.012420654296875
▁elev 8.7578125
ated 0.0027313232421875
▁prof 3.7421875
its 0.0012788772583007812
, 1.728515625
▁while 3.56640625
▁expl 3.873046875
oring 0.0008573532104492188
▁the 0.98828125
▁underlying 5.578125
▁concerns 2.568359375
▁surrounding 2.77734375
▁Eli 2.02734375
▁L 0.0015773773193359375
illy 0.002765655517578125
▁& 1.41015625
▁Co 0.008026123046875
' 0.2734375
s 0.0018186569213867188
▁profit 3.17578125
▁marg 3.017578125
ins 9.28640365600586e-05
. 0.2086181640625
<0x0A> 0.15673828125
R 5.125
ising 0.85546875
▁Prof 0.76513671875
its 0.397705078125
▁Am 4.84375
id 0.0017995834350585938
▁Pan 2.71484375
demic 0.00106048583984375
: 3.16796875
<0x0A> 0.85791015625
E 0.93359375
li 0.21533203125
▁L 0.0009241104125976562
illy 0.002971649169921875
▁& 0.291259765625
▁Co 0.005786895751953125
' 2.0078125
s 0.000946044921875
▁steady 7.45703125
▁success 5.9921875
▁can 4.71875
▁be 0.270263671875
▁attributed 0.38916015625
▁to 0.05364990234375
▁a 2.5625
▁range 3.857421875
▁of 0.0014314651489257812
▁factors 0.160888671875
, 0.409912109375
▁including 0.495849609375
▁its 2.193359375
▁strateg 4.7109375
ic 0.057373046875
▁focus 1.875
▁on 0.08233642578125
▁innov 2.87109375
ative 0.6806640625
▁medic 1.669921875
ines 0.260498046875
▁and 1.2998046875
▁strong 4.33203125
▁product 4.33984375
▁pipeline 1.1455078125
. 0.243408203125
▁During 5.296875
▁the 0.0888671875
▁third 0.763671875
▁quarter 0.1651611328125
, 0.60791015625
▁the 0.875
▁company 0.08526611328125
▁witness 4.16015625
ed 0.0005278587341308594
▁robust 2.099609375
▁sales 0.79736328125
▁of 0.4169921875
▁its 1.4423828125
▁block 3.775390625
b 0.0008721351623535156
uster 0.036041259765625
▁dru 2.57421875
gs 2.5033950805664062e-05
, 0.88330078125
▁such 2.57421875
▁as 0.0012788772583007812
▁Tr 2.943359375
ul 0.08935546875
icity 0.00029397010803222656
, 0.90576171875
▁T 3.521484375
alt 0.419921875
z 0.006587982177734375
, 0.1158447265625
▁and 0.55126953125
▁J 4.3515625
ard 0.376708984375
iance 0.0030364990234375
, 0.80810546875
▁all 4.9375
▁of 0.0643310546875
▁which 0.0007829666137695312
▁contribute 3.98046875
▁significantly 1.9892578125
▁to 0.0528564453125
▁its 0.9560546875
▁bottom 2.482421875
▁line 0.1529541015625
. 0.03094482421875
▁The 2.634765625
▁continued 5.30078125
▁demand 1.37109375
▁for 0.0193328857421875
▁these 0.66796875
▁medic 1.357421875
ations 1.6025390625
, 2.35546875
▁couple 1.232421875
d 0.00019729137420654297
▁with 0.0014410018920898438
▁successful 5.77734375
▁market 2.591796875
ing 0.0885009765625
▁strateg 1.9365234375
ies 3.9577484130859375e-05
▁and 1.943359375
▁en 5.3828125
hanced 0.0168304443359375
▁patient 3.064453125
▁access 1.0595703125
, 0.2666015625
▁is 2.376953125
▁anticip 4.22265625
ated 0.0005631446838378906
▁to 0.0016794204711914062
▁drive 0.916015625
▁substantial 5.7890625
▁re 1.966796875
venue 0.00043463706970214844
▁growth 0.1865234375
. 1.955078125
<0x0A> 0.5224609375
Add 3.541015625
itionally 0.016876220703125
, 0.00033664703369140625
▁Eli 0.98486328125
▁L 0.0005393028259277344
illy 0.0011806488037109375
' 2.248046875
s 0.0002791881561279297
▁recent 3.18359375
▁break 7.38671875
through 0.027435302734375
▁in 1.30859375
▁the 1.41796875
▁development 1.8466796875
▁of 0.044708251953125
▁COVID 2.900390625
- 0.0142822265625
1 0.002044677734375
9 2.6345252990722656e-05
▁treat 2.7109375
ments 5.1021575927734375e-05
▁has 1.5009765625
▁further 2.966796875
▁bol 1.9453125
ster 9.739398956298828e-05
ed 7.200241088867188e-05
▁its 0.40478515625
▁port 4.62109375
folio 0.0005025863647460938
. 0.67138671875
▁The 0.74609375
▁ph 4.48046875
arma 0.0017137527465820312
ce 0.11944580078125
ut 4.172325134277344e-06
ical 0.00017964839935302734
▁company 0.7451171875
' 2.146484375
s 0.00020754337310791016
▁mon 5.51171875
oc 0.01450347900390625
l 0.000873565673828125
onal 6.937980651855469e-05
▁ant 0.004512786865234375
ib 0.00010442733764648438
ody 0.37744140625
▁ther 1.830078125
apy 0.358642578125
, 0.44921875
▁b 1.5283203125
am 0.0018329620361328125
lan 0.0010280609130859375
iv 0.004337310791015625
im 0.00047278404235839844
ab 0.0004963874816894531
, 0.089111328125
▁received 3.76953125
▁Emer 1.7392578125
gency 0.00013363361358642578
▁Use 0.02252197265625
▁Author 0.00295257568359375
ization 0.00868988037109375
▁( 0.8115234375
E 0.006381988525390625
U 0.009796142578125
A 0.008056640625
) 0.012939453125
▁from 0.317138671875
▁the 0.047210693359375
▁US 1.744140625
▁Food 0.1260986328125
▁and 0.07781982421875
▁D 0.0006995201110839844
rug 1.5139579772949219e-05
▁Administration 0.005126953125
▁( 0.1036376953125
F 0.01114654541015625
DA 0.00011861324310302734
). 2.826171875
▁This 1.875
▁authorization 3.919921875
▁enables 3.083984375
▁Eli 3.23046875
▁L 0.0003752708435058594
illy 0.0009756088256835938
▁to 0.3740234375
▁supply 2.220703125
▁its 2.673828125
▁potentially 7.09765625
▁life 0.472412109375
- 0.005512237548828125
s 0.003215789794921875
aving 0.0003895759582519531
▁treatment 1.603515625
▁to 0.4130859375
▁COVID 2.9140625
- 0.018157958984375
1 0.00395965576171875
9 5.507469177246094e-05
▁patients 0.040618896484375
, 2.740234375
▁potentially 5.51953125
▁leading 3.587890625
▁to 0.006320953369140625
▁substantial 4.48828125
▁sales 2.208984375
▁and 2.845703125
▁financial 5.484375
▁g 0.8037109375
ains 3.2901763916015625e-05
. 0.75537109375
<0x0A> 0.2861328125
Con 4.4375
c 0.0152435302734375
ern 5.9604644775390625e-06
s 0.0411376953125
▁Over 0.54638671875
▁Prof 0.80810546875
it 0.07281494140625
▁Marg 0.5869140625
ins 3.135204315185547e-05
: 0.0604248046875
<0x0A> 0.0025501251220703125
Wh 2.5546875
ile 0.0004756450653076172
▁Eli 0.472900390625
▁L 0.00024127960205078125
illy 0.0012578964233398438
▁& 0.56103515625
▁Co 0.00201416015625
' 0.626953125
s 0.00038123130798339844
▁rising 4.08203125
▁prof 0.8056640625
its 6.902217864990234e-05
▁demonstrate 5.4765625
▁its 0.869140625
▁strong 2.0625
▁performance 2.369140625
, 0.828125
▁concerns 3.0859375
▁persist 2.83203125
▁over 0.408203125
▁profit 3.705078125
▁marg 0.5361328125
ins 5.817413330078125e-05
. 0.83935546875
▁The 1.3779296875
▁es 10.125
cal 0.0014104843139648438
ating 0.1995849609375
▁costs 1.876953125
▁of 0.48486328125
▁research 2.521484375
▁and 0.29736328125
▁development 0.0350341796875
, 1.9111328125
▁couple 2.560546875
d 0.0001119375228881836
▁with 0.0014238357543945312
▁invest 6.52734375
ments 0.124267578125
▁in 0.296875
▁expand 3.4453125
ing 0.0005712509155273438
▁its 0.6591796875
▁manufact 4.28515625
uring 0.00014197826385498047
▁capabilities 1.6865234375
, 0.296142578125
▁have 1.5126953125
▁s 6.53515625
que 0.305419921875
ez 0.00022912025451660156
ed 7.700920104980469e-05
▁marg 1.677734375
ins 0.0002008676528930664
▁for 3.046875
▁the 0.40185546875
▁company 0.2646484375
. 0.1634521484375
▁Additionally 2.37890625
, 0.0003170967102050781
▁increased 3.373046875
▁competition 0.544921875
▁within 3.46484375
▁the 0.130615234375
▁ph 0.41015625
arma 0.0004322528839111328
ce 0.0178375244140625
ut 1.9073486328125e-06
ical 6.198883056640625e-06
▁industry 0.2265625
, 1.9892578125
▁combined 4.30078125
▁with 0.00018918514251708984
▁the 1.857421875
▁imp 6.0234375
ending 0.09564208984375
▁exp 3.037109375
iration 0.2001953125
▁of 0.01464080810546875
▁pat 0.57568359375
ents 0.1300048828125
▁for 0.77294921875
▁some 2.291015625
▁of 0.281982421875
▁Eli 3.888671875
▁L 0.0011949539184570312
illy 0.0005025863647460938
' 0.305419921875
s 0.00012803077697753906
▁key 1.076171875
▁dru 0.49609375
gs 9.5367431640625e-07
, 0.06170654296875
▁pos 3.8515625
es 0.0009946823120117188
▁potential 3.017578125
▁pr 8.0859375
icing 0.00025963783264160156
▁challeng 2.275390625
es 4.0531158447265625e-06
. 0.88037109375
<0x0A> 0.765625
More 5.3828125
over 0.01800537109375
, 8.45193862915039e-05
▁on 5.12109375
going 0.06597900390625
▁discuss 5.72265625
ions 2.0742416381835938e-05
▁on 2.619140625
▁drug 2.787109375
▁pr 0.394775390625
icing 2.5272369384765625e-05
▁re 5.16015625
forms 0.0012712478637695312
▁within 3.298828125
▁the 0.132568359375
▁US 0.29248046875
▁health 2.720703125
care 0.076416015625
▁system 0.12005615234375
▁could 1.44140625
▁significantly 5.4765625
▁impact 0.304931640625
▁the 2.31640625
▁overall 6.05078125
▁profit 0.46630859375
ability 0.103271484375
▁of 0.10162353515625
▁ph 2.396484375
arma 0.0011644363403320312
ce 0.0203399658203125
ut 1.430511474609375e-06
ical 3.6954879760742188e-06
▁companies 0.1083984375
▁like 1.744140625
▁Eli 0.08514404296875
▁L 0.0005278587341308594
illy 0.00036978721618652344
. 2.12890625
▁Possible 7.80859375
▁changes 1.23046875
▁to 1.1787109375
▁drug 2.2421875
▁pr 0.537109375
icing 1.9669532775878906e-05
▁policies 1.783203125
▁and 3.404296875
▁increased 2.3203125
▁pressure 2.91796875
▁for 3.771484375
▁afford 3.96484375
able 0.26513671875
▁access 2.048828125
▁to 0.2314453125
▁medic 0.84521484375
ations 0.449462890625
▁could 0.4013671875
▁impact 2.791015625
▁the 2.1484375
▁company 0.533203125
' 0.01300811767578125
s 7.617473602294922e-05
▁pr 5.90234375
icing 0.0006632804870605469
▁power 2.630859375
▁and 1.033203125
▁ex 5.921875
ert 0.408447265625
▁down 1.5751953125
ward 0.020599365234375
▁pressure 0.043060302734375
▁on 0.0039825439453125
▁marg 1.15234375
ins 5.3763389587402344e-05
. 0.08233642578125
<0x0A> 0.423583984375
Out 6.30859375
look 0.03253173828125
▁and 4.2109375
▁Str 3.994140625
ateg 0.470703125
ies 0.344482421875
: 0.277587890625
<0x0A> 0.0028018951416015625
Des 2.462890625
p 0.00043201446533203125
ite 4.172325134277344e-05
▁the 1.3017578125
▁concerns 3.43359375
▁surrounding 1.1025390625
▁profit 2.90234375
▁marg 0.2020263671875
ins 0.00021648406982421875
, 0.09686279296875
▁Eli 0.387451171875
▁L 0.00012052059173583984
illy 0.001644134521484375
▁& 0.1724853515625
▁Co 0.0020160675048828125
▁remains 1.52734375
▁optim 1.2734375
istic 0.0008521080017089844
▁about 0.174560546875
▁its 0.25927734375
▁future 1.3349609375
▁growth 3.169921875
▁prospect 0.1690673828125
s 0.0005536079406738281
. 0.2169189453125
▁The 0.2088623046875
▁ph 2.953125
arma 0.00035309791564941406
ce 0.01403045654296875
ut 1.1920928955078125e-06
ical 2.2649765014648438e-06
▁manufact 6.62109375
urer 0.0088348388671875
▁continues 2.759765625
▁to 0.033416748046875
▁advance 5.96484375
▁its 0.13720703125
▁robust 5.9296875
▁research 3.7265625
▁and 0.394287109375
▁development 0.01180267333984375
▁pipeline 0.339111328125
, 0.383056640625
▁foc 3.767578125
using 0.0005002021789550781
▁on 0.043182373046875
▁innov 1.47265625
ative 0.080078125
▁ther 2.001953125
ap 0.0033779144287109375
ies 9.417533874511719e-06
▁for 1.796875
▁various 2.11328125
▁dise 0.912109375
ases 0.00011491775512695312
. 0.888671875
▁Moreover 2.892578125
, 7.2479248046875e-05
▁the 0.5361328125
▁company 0.0380859375
▁strateg 8.8046875
izes 3.5390625
▁to 1.12890625
▁expand 1.572265625
▁its 0.197509765625
▁global 2.78515625
▁presence 1.7353515625
▁through 1.318359375
▁partners 2.98828125
hips 0.01313018798828125
▁and 0.62646484375
▁ac 0.29345703125
quis 0.026519775390625
itions 5.0067901611328125e-05
, 0.87158203125
▁aim 2.32421875
ing 0.47998046875
▁to 0.0144805908203125
▁divers 4.359375
ify 0.00039124488830566406
▁its 0.1761474609375
▁re 1.2138671875
venue 0.001674652099609375
▁streams 0.8583984375
▁and 0.4482421875
▁reduce 4.15234375
▁dependency 3.08984375
▁on 0.00711822509765625
▁individual 4.96875
▁block 4.14453125
b 4.9948692321777344e-05
uster 0.10174560546875
▁dru 0.493896484375
gs 1.3113021850585938e-06
. 0.02020263671875
<0x0A> 0.39404296875
E 1.9599609375
li 0.11669921875
▁L 0.0006866455078125
illy 0.0009174346923828125
▁& 0.14013671875
▁Co 0.004123687744140625
▁is 1.8076171875
▁also 1.623046875
▁eng 6.203125
aging 0.004528045654296875
▁in 0.05426025390625
▁on 6.62890625
going 0.058441162109375
▁efforts 1.69921875
▁to 0.035064697265625
▁manage 5.4609375
▁costs 0.92724609375
▁effectively 5.33984375
▁and 1.427734375
▁optimize 3.072265625
▁its 1.1806640625
▁manufact 1.181640625
uring 7.474422454833984e-05
▁processes 1.826171875
. 0.8818359375
▁By 3.12109375
▁en 4.99609375
han 0.046417236328125
cing 2.0265579223632812e-06
▁oper 2.98828125
ational 0.00027441978454589844
▁effic 0.83544921875
ien 0.002620697021484375
cies 1.6808509826660156e-05
▁and 0.52001953125
▁expl 4.9140625
oring 0.0008244514465332031
▁techn 4.359375
ological 0.455078125
▁adv 0.65625
anc 0.071533203125
ements 3.814697265625e-06
, 0.2109375
▁the 0.06988525390625
▁company 0.10931396484375
▁a 1.4755859375
ims 2.2411346435546875e-05
▁to 0.0017652511596679688
▁counter 8.234375
▁the 1.595703125
▁challeng 1.677734375
es 0.044403076171875
▁pos 0.35888671875
ed 0.00010216236114501953
▁by 0.0031909942626953125
▁rising 1.9228515625
▁costs 1.3779296875
▁and 0.67138671875
▁potential 3.826171875
▁pr 1.099609375
icing 1.8358230590820312e-05
▁press 2.24609375
ures 2.002716064453125e-05
. 0.1837158203125
<0x0A> 1.498046875
Con 3.654296875
clusion 0.79248046875
: 0.063720703125
<0x0A> 1.3994140625
E 0.890625
li 0.09124755859375
▁L 0.0001811981201171875
illy 0.0011348724365234375
▁& 0.0374755859375
▁Co 0.003314971923828125
' 0.88232421875
s 0.001911163330078125
▁third 1.6982421875
- 0.035980224609375
qu 0.00027251243591308594
arter 1.9550323486328125e-05
▁ear 0.286865234375
nings 0.006195068359375
▁are 0.77197265625
▁expected 0.626953125
▁to 0.0015249252319335938
▁show 2.5546875
case 0.7666015625
▁a 1.791015625
▁strong 1.546875
▁up 7.51953125
ward 0.030609130859375
▁traject 0.161376953125
ory 3.540515899658203e-05
▁in 2.814453125
▁prof 2.041015625
its 0.0016155242919921875
, 0.97314453125
▁primarily 5.734375
▁fue 3.646484375
led 1.0728836059570312e-05
▁by 0.0005245208740234375
▁robust 0.308349609375
▁sales 0.10491943359375
▁of 0.08770751953125
▁their 9.21875
▁block 1.4580078125
b 4.7206878662109375e-05
uster 0.0177001953125
▁dru 0.281494140625
gs 1.6689300537109375e-06
▁and 2.638671875
▁break 5.5859375
through 0.0006866455078125
s 3.259765625
▁in 0.042236328125
▁COVID 1.4365234375
- 0.006320953369140625
1 0.002197265625
9 3.24249267578125e-05
▁treat 0.4423828125
ments 7.224082946777344e-05
. 0.03546142578125
▁However 1.34765625
, 0.0001723766326904297
▁concerns 1.611328125
▁l 5.53515625
inger 0.0285186767578125
▁over 0.31640625
▁their 5.35546875
▁profit 0.76611328125
▁marg 0.190185546875
ins 2.276897430419922e-05
, 0.46728515625
▁stem 5.1484375
ming 0.0028228759765625
▁from 0.017852783203125
▁rising 1.8095703125
▁costs 0.3623046875
▁of 0.76318359375
▁research 0.1907958984375
▁and 0.028961181640625
▁development 0.00328826904296875
, 0.33251953125
▁potential 2.87109375
▁pr 0.46533203125
icing 3.337860107421875e-05
▁press 0.447265625
ures 8.702278137207031e-06
, 0.319580078125
▁and 0.04534912109375
▁drug 8.015625
▁pr 1.294921875
icing 3.254413604736328e-05
▁re 0.22265625
forms 0.00026535987854003906
. 0.9677734375
▁The 2.447265625
▁company 0.370849609375
' 1.5322265625
s 7.426738739013672e-05
▁future 3.40625
▁success 1.7158203125
▁h 1.8759765625
ing 0.007808685302734375
es 0.00017881393432617188
▁on 0.128173828125
▁its 0.4931640625
▁ability 0.31591796875
▁to 0.0013866424560546875
▁effectively 2.412109375
▁manage 0.276611328125
▁these 1.1171875
▁challeng 0.646484375
es 0.0012960433959960938
, 1.966796875
▁while 0.364990234375
▁continu 2.189453125
ing 0.10333251953125
▁to 0.078369140625
▁innov 3.025390625
ate 0.000995635986328125
▁and 0.52978515625
▁expand 0.83837890625
▁its 0.1746826171875
▁product 1.7021484375
▁port 0.363525390625
folio 0.0004906654357910156
. 0.26416015625
